Published in Lancet Infect Dis on November 08, 2012
Research Investments in Global Health: A Systematic Analysis of UK Infectious Disease Research Funding and Global Health Metrics, 1997-2013. EBioMedicine (2015) 1.43
Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997-2010. J Antimicrob Chemother (2013) 1.34
The 10 largest public and philanthropic funders of health research in the world: what they fund and how they distribute their funds. Health Res Policy Syst (2016) 1.30
Differences in research funding for women scientists: a systematic comparison of UK investments in global infectious disease research during 1997-2010. BMJ Open (2013) 1.17
Systematic analysis of funding awarded for norovirus research to institutions in the United Kingdom, 1997-2010. J R Soc Med (2013) 1.10
Funding infectious disease research: a systematic analysis of UK research investments by funders 1997-2010. PLoS One (2014) 1.05
Investments in respiratory infectious disease research 1997-2010: a systematic analysis of UK funding. BMJ Open (2014) 1.05
Global health priorities and research funding. Lancet Infect Dis (2013) 1.03
Global health priorities and research funding. Lancet Infect Dis (2013) 1.02
Global health priorities and research funding--authors' reply. Lancet Infect Dis (2013) 0.93
Antibiotic use and emerging resistance: how can resource-limited countries turn the tide? Glob Heart (2014) 0.91
Mapping pneumonia research: A systematic analysis of UK investments and published outputs 1997-2013. EBioMedicine (2015) 0.89
Comparing research investment to United Kingdom institutions and published outputs for tuberculosis, HIV and malaria: a systematic analysis across 1997-2013. Health Res Policy Syst (2015) 0.86
Systematic analysis of funding awarded for viral hepatitis-related research to institutions in the United Kingdom, 1997-2010. J Viral Hepat (2014) 0.84
Systematic analysis of funding awarded to institutions in the United Kingdom for infectious disease research, 1997-2010. JRSM Open (2015) 0.84
Systematic analysis of funding awarded for mycology research to institutions in the UK, 1997-2010. BMJ Open (2014) 0.83
Review of Antimicrobial Resistance in the Environment and Its Relevance to Environmental Regulators. Front Microbiol (2016) 0.82
Improving Control of Antibiotic-Resistant Gonorrhea by Integrating Research Agendas Across Disciplines: Key Questions Arising From Mathematical Modeling. J Infect Dis (2015) 0.82
Mapping the terrain of investment in global infectious diseases. Lancet Infect Dis (2012) 0.79
Investing in sepsis research: systematic analysis of UK public and philanthropic funding 1997-2010. JRSM Open (2014) 0.78
Global health equity in United Kingdom university research: a landscape of current policies and practices. Health Res Policy Syst (2016) 0.78
Investments in sexually transmitted infection research, 1997-2013: a systematic analysis of funding awarded to UK institutions. J Glob Health (2015) 0.78
Pre-cut Filter Paper for Detecting Anti-Japanese Encephalitis Virus IgM from Dried Cerebrospinal Fluid Spots. PLoS Negl Trop Dis (2016) 0.77
Less talk, more action. Nat Rev Microbiol (2013) 0.75
Ebola research funding: a systematic analysis, 1997-2015. J Glob Health (2016) 0.75
Mapping Investments and Published Outputs in Norovirus Research: A Systematic Analysis of Research Funded in the United States and United Kingdom During 1997-2013. J Infect Dis (2016) 0.75
The activity of the Research Investments in Global Health study and ways forward within the global funding and policy landscape. BMC Proc (2016) 0.75
Towards an improved investment approach for an effective response to HIV/AIDS. Lancet (2011) 11.89
An assessment of interactions between global health initiatives and country health systems. Lancet (2009) 10.53
Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet (2010) 6.84
Technologies for global health. Lancet (2012) 5.05
Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach. Lancet (2011) 5.00
Equity and adequacy of international donor assistance for global malaria control: an analysis of populations at risk and external funding commitments. Lancet (2010) 3.73
Mobile phone messaging for facilitating self-management of long-term illnesses. Cochrane Database Syst Rev (2012) 3.70
Universal access to malaria medicines: innovation in financing and delivery. Lancet (2010) 3.31
The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis. Lancet Infect Dis (2012) 3.26
Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis (2009) 2.97
Mobile phone messaging reminders for attendance at healthcare appointments. Cochrane Database Syst Rev (2012) 2.87
Is operational research delivering the goods? The journey to success in low-income countries. Lancet Infect Dis (2012) 2.62
Risk factors for pulmonary tuberculosis in Russia: case-control study. BMJ (2005) 2.44
Mobile phone messaging reminders for attendance at healthcare appointments. Cochrane Database Syst Rev (2013) 2.42
Mobile phone messaging for preventive health care. Cochrane Database Syst Rev (2012) 2.15
Economic returns to investment in AIDS treatment in low and middle income countries. PLoS One (2011) 1.98
Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. J Infect Dis (2012) 1.89
Funding for malaria control 2006-2010: a comprehensive global assessment. Malar J (2012) 1.87
Guidance for evidence-informed policies about health systems: rationale for and challenges of guidance development. PLoS Med (2012) 1.81
Influenza infection and risk of acute myocardial infarction in England and Wales: a CALIBER self-controlled case series study. J Infect Dis (2012) 1.73
Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs. J Infect Dis (2012) 1.72
Social, economic, human rights and political challenges to global mental health. Ment Health Fam Med (2011) 1.72
Market failure and the poverty of new drugs in maternal health. PLoS Med (2008) 1.70
Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action. Lancet (2010) 1.69
Guidance for evidence-informed policies about health systems: linking guidance development to policy development. PLoS Med (2012) 1.68
Integrating tuberculosis and HIV services in low- and middle-income countries: a systematic review. Trop Med Int Health (2012) 1.66
Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality. Bull World Health Organ (2011) 1.64
Global health initiative investments and health systems strengthening: a content analysis of global fund investments. Global Health (2013) 1.60
International and national policy challenges in mental health. Ment Health Fam Med (2011) 1.58
An analysis of GAVI, the Global Fund and World Bank support for human resources for health in developing countries. Health Policy Plan (2012) 1.58
Relative and absolute addressability of global disease burden in maternal and perinatal health by investment in R&D. Trop Med Int Health (2011) 1.57
Health systems strengthening: a common classification and framework for investment analysis. Health Policy Plan (2010) 1.56
Health system challenges and solutions to improving mental health outcomes. Ment Health Fam Med (2011) 1.53
Beyond borders: public-health surveillance. Lancet (2006) 1.49
Public-private partnerships for hospitals. Bull World Health Organ (2006) 1.46
Logistic issues and potential prescribing costs associated with use of neuraminidase inhibitors for the treatment of influenza in primary care. J R Soc Med (2003) 1.44
Integrating prevention of mother-to-child HIV transmission (PMTCT) programmes with other health services for preventing HIV infection and improving HIV outcomes in developing countries. Cochrane Database Syst Rev (2011) 1.41
Health systems, systems thinking and innovation. Health Policy Plan (2012) 1.41
Antibacterial prescribing in primary care. J Antimicrob Chemother (2007) 1.41
Integrating prevention of mother-to-child HIV transmission programs to improve uptake: a systematic review. PLoS One (2012) 1.40
Tuberculosis in prisons in sub-Saharan Africa--the need for improved health services, surveillance and control. Tuberculosis (Edinb) (2011) 1.40
Rethinking health systems strengthening: key systems thinking tools and strategies for transformational change. Health Policy Plan (2012) 1.34
Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997-2010. J Antimicrob Chemother (2013) 1.34
Effect of investment in malaria control on child mortality in sub-Saharan Africa in 2002-2008. PLoS One (2011) 1.32
Prevention of HIV/AIDS among injecting drug users in Russia: opportunities and barriers to scaling-up of harm reduction programmes. Health Policy (2007) 1.31
Health systems, communicable diseases and integration. Health Policy Plan (2010) 1.29
Mental health and the global agenda: core conceptual issues. Ment Health Fam Med (2011) 1.28
Novel vectors of malaria parasites in the western highlands of Kenya. Emerg Infect Dis (2012) 1.26
Why do health systems matter? Exploring links between health systems and HIV response: a case study from Russia. Health Policy Plan (2010) 1.23
Mobile phone messaging for communicating results of medical investigations. Cochrane Database Syst Rev (2012) 1.23
Scaling up research and learning for health systems: time to act. Lancet (2008) 1.22
Positive spill-over effects of ART scale up on wider health systems development: evidence from Ethiopia and Malawi. J Int AIDS Soc (2011) 1.22
Antimicrobial prescribing patterns for respiratory diseases including tuberculosis in Russia: a possible role in drug resistance? J Antimicrob Chemother (2004) 1.19
Differences in research funding for women scientists: a systematic comparison of UK investments in global infectious disease research during 1997-2010. BMJ Open (2013) 1.17
Long-term costs and health impact of continued global fund support for antiretroviral therapy. PLoS One (2011) 1.16
The uptake of integrated perinatal prevention of mother-to-child HIV transmission programs in low- and middle-income countries: a systematic review. PLoS One (2013) 1.14
Global Fund financing of public-private mix approaches for delivery of tuberculosis care. Trop Med Int Health (2011) 1.11
Systematic analysis of funding awarded for norovirus research to institutions in the United Kingdom, 1997-2010. J R Soc Med (2013) 1.10
Mental health reform in the Russian Federation: an integrated approach to achieve social inclusion and recovery. Bull World Health Organ (2007) 1.08
Simulation of malaria epidemiology and control in the highlands of Western Kenya. Malar J (2012) 1.06
Investments in respiratory infectious disease research 1997-2010: a systematic analysis of UK funding. BMJ Open (2014) 1.05
Long-term care of AIDS and non-communicable diseases. Lancet (2011) 1.04
Viewpoint: Scientific dogmas, paradoxes and mysteries of latent Mycobacterium tuberculosis infection. Trop Med Int Health (2011) 1.03
Implementing the global plan to stop TB, 2011-2015--optimizing allocations and the Global Fund's contribution: a scenario projections study. PLoS One (2012) 1.01
Spatial methods for infectious disease outbreak investigations: systematic literature review. Euro Surveill (2015) 1.01
Scaling up towards international targets for AIDS, tuberculosis, and malaria: contribution of global fund-supported programs in 2011-2015. PLoS One (2011) 1.01
Near patient testing for influenza in children in primary care: comparison with laboratory test. BMJ (2003) 1.01
Eliminating tuberculosis and tuberculosis-HIV co-disease in the 21st century: key perspectives, controversies, unresolved issues, and needs. J Infect Dis (2012) 0.99
Tuberculosis and tuberculosis/HIV/AIDS-associated mortality in Africa: the urgent need to expand and invest in routine and research autopsies. J Infect Dis (2012) 0.99
Infectious disease research investments follow colonial ties: questionable ethics. Int Health (2014) 0.97
HIV epidemics and prevention responses in Asia and Eastern Europe: lessons to be learned? AIDS (2010) 0.96
Bringing neglected tropical diseases into the spotlight. Trends Parasitol (2010) 0.95
Research on implementation of interventions in tuberculosis control in low- and middle-income countries: a systematic review. PLoS Med (2012) 0.95
Interactions between critical health system functions and HIV/AIDS, tuberculosis and malaria programmes. Health Policy Plan (2010) 0.95
Hand hygiene to reduce community transmission of influenza and acute respiratory tract infection: a systematic review. Influenza Other Respir Viruses (2012) 0.94
Adoption of rapid diagnostic tests for the diagnosis of malaria, a preliminary analysis of the Global Fund program data, 2005 to 2010. PLoS One (2012) 0.94
Global health priorities and research funding--authors' reply. Lancet Infect Dis (2013) 0.93
A conceptual and analytical approach to comparative analysis of country case studies: HIV and TB control programmes and health systems integration. Health Policy Plan (2010) 0.93
Investing in improved performance of national tuberculosis programs reduces the tuberculosis burden: analysis of 22 high-burden countries, 2002-2009. J Infect Dis (2012) 0.90
The Global Fund's resource allocation decisions for HIV programmes: addressing those in need. J Int AIDS Soc (2011) 0.90
Public-private partnership in cord blood banking. BMJ (2008) 0.88
Should development agencies care about mental health? Ment Health Fam Med (2011) 0.88
Use of primary care data for detecting impetigo trends, United kingdom, 1995-2010. Emerg Infect Dis (2013) 0.87
Innovating for impact: the Affordable Medicines Facility-malaria (AMFm). Nat Med (2009) 0.87
Know your epidemic, know your response: targeting HIV in Asia. AIDS (2010) 0.87